Alpine Zanubrutinib Trial Data: Implications for BTK Inhibitor Selection in CLL
Over the past decade, the treatment landscape for Chronic Lymphocytic Leukemia (CLL) has evolved substantially with the introduction of Bruton tyrosine kinase (BTK) inhibitors, which are widely used across multiple…